Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00445406
What this trial is testing

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 43
Testing effectiveness (Phase 2)Ended earlyNCT02738606
What this trial is testing

Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+5 more
M.D. Anderson Cancer Center 29
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Testing effectiveness (Phase 2)UnknownNCT00098852
What this trial is testing

Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
University of California, San Francisco 25
Testing effectiveness (Phase 2)WithdrawnNCT04119830
What this trial is testing

Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaMicrosatellite StableMismatch Repair Proficient+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00022633
What this trial is testing

S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 65
Early research (Phase 1)Study completedNCT00575393
What this trial is testing

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT00005971
What this trial is testing

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 17
Not applicableStudy completedNCT00483821
What this trial is testing

A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 165
Testing effectiveness (Phase 2)UnknownNCT00471484
What this trial is testing

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
National Cancer Centre, Singapore 54
Testing effectiveness (Phase 2)Study completedNCT00004233
What this trial is testing

S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
SWOG Cancer Research Network 65
Testing effectiveness (Phase 2)UnknownNCT00005958
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Amgen
Testing effectiveness (Phase 2)Active Not RecruitingNCT03137771
What this trial is testing

Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
NRG Oncology 218
Large-scale testing (Phase 3)Looking for participantsNCT07154706
What this trial is testing

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Nuvation Bio Inc. 180
Testing effectiveness (Phase 2)Study completedNCT00074230
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma

Who this might be right for
Melanoma (Skin)
University Hospital Erlangen 82
Not applicableStudy completedNCT00900328
What this trial is testing

Study of Tumor Samples From Patients With Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 280
Large-scale testing (Phase 3)Study completedNCT00060320
What this trial is testing

Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer

Who this might be right for
Breast CancerHot Flashes
Alliance for Clinical Trials in Oncology 132
Early research (Phase 1)Study completedNCT00002946
What this trial is testing

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692103
What this trial is testing

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Who this might be right for
Estrogen Receptor PositivePrimary or Recurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 2
Testing effectiveness (Phase 2)Looking for participantsNCT07673627
What this trial is testing

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

Who this might be right for
AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia Gravis (MG)MG - Myasthenia Gravis+1 more
argenx 40
Next Page